Bleakley Financial Group’s Lyell Immunopharma LYEL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-921	Closed	-$26.7K	–	1060
2024 Q2	$26.7K	Sell	921 -371	-29%	-$10.8K	﹤0.01%	997
2024 Q1	$57.6K	Sell	1,292 -1,113	-46%	-$49.6K	﹤0.01%	956
2023 Q4	$93.3K	Buy	+2,405	New	+$93.3K	﹤0.01%	900